Harvey-Bradshaw Index (HBI) for Crohn's Disease

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۵۰

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
hbi score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Remission0–4
  • Mild Disease5–7
  • Moderate Disease8–16
  • Severe Disease17–100
Direct Clinical Answer

The Harvey-Bradshaw Index (HBI) for Crohn's Disease calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include general wellbeing. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Stratifies severity of Crohn's disease using only clinical parameters. A simplified version of the Crohn's Disease Activity Index (CDAI) that correlates 93% with CDAI but doesn't require laboratory tests.

Clinical Indication

The Harvey-Bradshaw Index (HBI) for Crohn's Disease is indicated for bedside clinical practice to support Stratifies severity of Crohn's disease using only clinical parameters. A simplified version of the Crohn's Disease Activity Index (CDAI) that correlates 93% with CDAI but doesn't require laboratory tests.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: A reduction of 3 points is considered clinically significant response to treatment.

Formula & Variables:

HBI Score = General well-being (0-4) + Abdominal pain (0-3) + Number of liquid stools (1 point per stool) + Abdominal mass (0-3) + Complications (1 point each)

Input Parameters

NameTypeRequiredDescription
general_wellbeingintegerYesGeneral well-being (assessed for the previous day)
abdominal_painintegerYesAbdominal pain (assessed for the previous day)
liquid_stoolsintegerYesNumber of liquid or soft stools per day (assessed for the previous day)
abdominal_massintegerYesAbdominal mass on examination
complicationsarrayYesExtra-intestinal manifestations (1 point each)

Score Interpretation & Guidance

RangeStageDescription
0–4RemissionDisease in remission
5–7Mild DiseaseMild disease activity
8–16Moderate DiseaseModerate disease activity
17–100Severe DiseaseSevere disease activity

Evidence-Based References (EBM)

  • Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514. doi: 10.1016/s0140-6736(80)92767-1.DOI: 10.1016/s0140-6736(80)92767-1
  • Peyrin-Biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, et al. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clin Gastroenterol Hepatol. 2016 Mar;14(3):348-354.e17. doi: 10.1016/j.cgh.2015.06.001.DOI: 10.1016/j.cgh.2015.06.001
  • Gomes P, du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986 Jan;27(1):92-5. doi: 10.1136/gut.27.1.92.DOI: 10.1136/gut.27.1.92

Related calculators